Ischemic stroke associated with the use of a synthetic cannabinoid (spice)
Möller S, Luecke C, Struffert T, Schwarze B, Gerner S, Schwab S, Köhrmann M, Machold K, Philipsen A, Mueller HH (2017)
Publication Type: Journal article
Publication year: 2017
Journal
Book Volume: 25
Pages Range: 127-130
DOI: 10.1016/j.ajp.2016.10.019
Abstract
Synthetic cannabinoids, i.e. "spice", are psychoactive drugs with increasing use worldwide. Spice may have harmful neuropsychiatric and physical side effects. Here, we present the case of a 25-year-old man with ischemic stroke after smoking spice on the previous evening. Diagnostic work-up was negative for other common causes of stroke. Toxicology screen unveiled the cannabimimetic ADB-FUBINACA in the drug sample and in patient's urine. The cardiac sympathomimetic effect of spice might have triggered an unnoticed episode of tachyarrhythmia and resulted in stroke via cardioembolic etiology. Thus, in absence of other risk factors, a careful patient history of spice use is recommended for patients with acute neurological deficits.
Authors with CRIS profile
Sebastian Möller
Department of Neurology
Stefan Gerner
Department of Neurology
Stefan Schwab
Lehrstuhl für Neurologie
Martin Köhrmann
Medizinische Fakultät
Kristin Machold
Medizinische Fakultät
Involved external institutions
Germany (DE)How to cite
APA:
Möller, S., Luecke, C., Struffert, T., Schwarze, B., Gerner, S., Schwab, S.,... Mueller, H.H. (2017). Ischemic stroke associated with the use of a synthetic cannabinoid (spice). Asian Journal of Psychiatry, 25, 127-130. https://doi.org/10.1016/j.ajp.2016.10.019
MLA:
Möller, Sebastian, et al. "Ischemic stroke associated with the use of a synthetic cannabinoid (spice)." Asian Journal of Psychiatry 25 (2017): 127-130.
BibTeX: Download